language_icon
EN
HI

Poly Medicure Share price

POLYMED

1459.4

4.30 (0.30%)
NSE
BSE
Last updated on 20 May, 2026 | 15:30 IST
Today's High

1489.00

Today's Low

1428.20

52 Week Low

1182.00

52 Week High

2529.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Poly Medicure Chart

Poly Medicure Share Key Metrics

Volume
83292.00
Market Cap
14792.40 CR
LTQ@LTP
1@1459.40
ATP
1461.13
Var Margin
20.98 %
Circuit Range
1164.1-1746.1
Delivery %
39.42 %
Value
12.17 CR
ASM/GSM
No
Market Lot
1

Summary

Poly Medicure share price is ₹1459.4 as of 20 May, 2026. The stock Poly Medicure intraday movement has stayed between ₹1428.20 and ₹1489.00, while on a 52-week basis,Poly Medicure price 52 week high is ₹2529.90 & its 52 week low is ₹1182.00.
In terms of trading activity, Poly Medicure has recorded a volume of 83292 shares, The Poly Medicure has a market cap of ₹101359490 CR. The stock’s Average Traded Price (ATP) stands at ₹1461.13, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1459.40.
Poly Medicure operates within a circuit range of ₹1164.10 – ₹1746.10, with a Value of ₹12.17 CR. The Delivery Percentage for the day is 39.42%. Additionally, Poly Medicure currently falls under the No framework, and trades with a market lot size of 1.

Poly Medicure Fundamentals

View More
P/E Ratio

42.42

P/B Ratio

4.94

Div. Yield

0.24

Sector P/E

58.01

Sector P/B

2.91

Sec. Div. Yield

0.07

Poly Medicure Resistance and Support

Pivot 1463.07

Resistance

First Resistance

1481.94

Second Resistance

1508.77

Third Resistance

1527.64

Support

First Support

1436.24

Second Support

1417.37

Third Support

1390.54

Poly Medicure Shareholding Pattern

View More
  • 2024-25
  • 2023-24
  • 2022-23
  • 2021-22
  • 2020-21
  • 2019-20
  • 2018-19
  • 2016-17
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

48.77%

Mutual Fund

0.02%

Insurance

0%

Foreign Institutional Investors

3.75%

Domestic Institutional Investors

0.24%

Retail

47.22%

Others

0%

Total Promoters
SEP '20
48.76%
DEC '20
48.77%

Poly Medicure Corporate Actions

DateAgenda
2026-05-25Audited Results & Final Dividend
2026-02-05Quarterly Results
2025-11-08Quarterly Results
2025-08-08Quarterly Results & Others
2025-05-06Audited Results & Final Dividend
2025-02-03Quarterly Results & Others

Poly Medicure News

Poly Medicure Limited

Poly Medicure's QIP proceeds utilization report revealed deviation from offer document, with unutilized funds of Rs.71.87 crore invested in hybrid mutual funds, exposing them to market risks. Additionally, capital expenditure projects face implementation delays, rescheduling targets to FY27-FY28.
May 15 2026 20:05:00

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Poly Medicure's monitoring agency report for Q4 FY26 highlights deviations in the utilization of QIP funds. Unutilized proceeds amounting to Rs.7,187.58 lakh were invested in hybrid mutual funds with equity exposure, contrary to the QIP placement document. Additionally, manufacturing facility projects, including the SEZ Jaipur project, are delayed, with expenditure now rescheduled to FY27-28.
May 15 2026 20:05:00

Poly Medicure Limited

POLY MEDICURE LIMITED board meeting is scheduled for May 25, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 2026, along with a final dividend.
May 14 2026 17:05:00

Poly Medicure Limited

POLY MEDICURE LIMITED board meeting is scheduled for May 25, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 2026, along with a final dividend.
May 14 2026 17:05:00

Poly Medicure Limited

Poly Medicure board will convene on May 25, 2026, to consider and approve its audited standalone and consolidated financial results for Q4 FY26 and the full financial year. The board will also deliberate on the recommendation of a final dividend.
May 14 2026 17:05:00

Poly Medicure Limited

Poly Medicure's Board will meet on May 25, 2026, to review and approve the audited financial results for the financial year ended March 31, 2026. The board will also consider recommending a final dividend for the same period.
May 14 2026 17:05:00

Poly Medicure Ltd - 531768 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th May, 2026

Poly Medicure's board will convene on May 25, 2026, to consider and approve the audited financial results and recommend a final dividend for the financial year ended March 31, 2026.
May 14 2026 17:05:00

Poly Medicure Limited

Poly Medicure Limited's wholly-owned subsidiary, Polymed Brazil LTDA, acquired 100% equity in MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA. This acquisition enables Polymed Brazil to commercialize medical devices in Brazil by gaining necessary operating licenses, including for importation and distribution.
Apr 30 2026 20:04:00

Poly Medicure Limited

Poly Medicure's wholly-owned subsidiary, Polymed Brazil LTDA, has acquired 100% equity of MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA for R$180,000. This acquisition secures all necessary operating licenses for Polymed Brazil LTDA to commercialize and distribute medical devices in Brazil.
Apr 30 2026 20:04:00

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Acquisition

Poly Medicure's wholly-owned subsidiary, Polymed Brazil LTDA, acquired 100% equity in MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA for R$180,000. This acquisition grants Polymed Brazil access to necessary operating licenses for importing and commercializing medical devices in Brazil.
Apr 30 2026 19:04:00
Read More

About Poly Medicure

NSE : 25718  
BSE : 531768  
ISIN : INE205C01021  

Poly Medicure Management

NamePosition
Devendra MehtaChairman
Jugal Kishore BaidNon Independent & Non Executive Director
View More

Poly Medicure FAQs

The Buying Price of Poly Medicure share is 1459.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Poly Medicure stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Poly Medicure, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Poly Medicure shares is 42.42. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Poly Medicure shares is 4.94. Useful to assess the stock's value relative to its book value.

To assess Poly Medicure’s valuation compare Sector P/E, P/B which are 58.01 & 2.91 with sector averages, along with growth rates and financial metrics.

The Market Cap of Poly Medicure is 14792.40 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Poly Medicure share price is 2529.90 & 1182.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Poly Medicure belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost